• 1
    Nyland TG, Mattoon JS, Herrgesell ER, Wisner ER. Spleen. In: NylandTG, MattoonJS, eds. Small Animal Diagnostic Ultrasound, 2nd ed. Philadelphia, PA: Saunders; 2002:128143.
  • 2
    Blomley MJ, Albrecht T, Schlief R, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: Early experience. Radiology 1999;210:409416.
  • 3
    Hatanaka K, Kudo M, Minami Y, Maekawa K. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: Comparison with contrast-enhanced CT. Oncology 2008;75 (Suppl 1):4247.
  • 4
    Von Herbay A, Barreiros AP, Ignee A, et al. Contrast-enhanced ultrasonography with SonoVue: Differentiation between benign and malignant lesions of the spleen. J Ultrasound Med 2009;28:421434.
  • 5
    Rossi F, Leone VF, Vignoli M, et al. Use of contrast-enhanced ultrasound for characterization of focal splenic lesions. Vet Radiol Ultrasound 2008;49:154164.
  • 6
    Ohlerth S, Dennler M, Rüefli E, et al. Contrast harmonic imaging characterization of canine splenic lesions. J Vet Intern Med 2008;22:10951102.
  • 7
    Ivancić M, Long F, Seiler GS. Contrast harmonic ultrasonography of splenic masses and associated liver nodules in dogs. J Am Vet Med Assoc 2009;234:8894.
  • 8
    Yanagisawa K, Moriyasu F, Miyahara T, et al. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007;33:318325.
  • 9
    Watanabe R, Matsumura M, Munemasa T, et al. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: Microscopic studies in rat liver. Invest Radiol 2007;42:643651.
  • 10
    Watanabe R, Matsumura M, Chen CJ, et al. Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model. Biol Pharm Bull 2003;26:12721277.
  • 11
    Hatanaka K, Kudo M, Minami Y, et al. Differential diagnosis of hepatic tumors: Value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008;5:6169.
  • 12
    Inoue T, Kudo M, Hatanaka K, et al. Imaging of hepatocellular carcinoma: Qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images. Oncology 2008;75 (Suppl 1):4854.
  • 13
    Kanemoto H, Ohno K, Nakashima K, et al. Characterization of canine focal liver lesions with contrast-enhanced ultrasound using a novel contrast agent-Sonazoid. Vet Radiol Ultrasound 2009;50:188194.
  • 14
    Nakamura K, Takagi S, Takiguchi M, et al. Contrast-enhanced ultrasonography for characterization of canine focal liver lesions. Vet Radiol Ultrasound 2010;51:7985.
  • 15
    Nakamura K, Sasaki N, Takiguchi M, et al. Quantitative contrast-enhanced ultrasonography of canine spleen. Vet Radiol Ultrasound 2009;50:104108.
  • 16
    Fabry A, Benjamin SA, Angleton GM. Nodular hyperplasia of the liver in the Beagle dog. Vet Pathol 1982;19:109119.
  • 17
    Fry MM, McGavin MD. Bone marrow, blood cells, and lymphatic system. In: McGavinMD, ZacharyJF, eds. Pathologic Basis of Veterinary Disease, 4th ed. St Louis, MO: Mosby; 2007:743832.
  • 18
    Lim AKP, Patel N, Eckersley RJ, et al. Evidence for spleen-specific uptake of a microbubble contrast agent: A quantitative study in healthy volunteers. Radiology 2004;231:785788.
  • 19
    Ohlerth S, Ruefli E, Poirier V, et al. Contrast harmonic imaging of the normal canine spleen. Vet Radiol Ultrasound 2007;48:451456.
  • 20
    Görg C. The forgotten organ: Contrast enhanced sonography of the spleen. Eur J Radiol 2007;64:189201.
  • 21
    Fife WD, Samii VF, Drost WT, et al. Comparison between malignant and nonmalignant splenic masses in dogs using contrast-enhanced computed tomography. Vet Radiol Ultrasound 2004;45:289297.